ATAD2 and cancer: Our results demonstrate that a high ATAD2 level is significantly associated with a worse outcome in ACC, KIRP, LGG, LUAD, MESO, PAAD TCGA tumors, strongly suggesting that ATAD2 overexpression favors malignant transformation of unrelated cancer types.